Biotech firm Vivox has developed its first product and is seeking investors  

Århus based Vivox has developed a patented mini-laboratory and is seeking for DKK 10 mn in capital to bring it to market

Århus based fledgling firm Vivix has developed its first product, a patented mini-laboratory for safe and correct handling of biological material including stem cells. Vivox has invested DKK 40 mn (USD 7.2 mn) in the project, in terms of capital and assessed value of research time. The company is now looking for investments of DKK 10 mn (USD 1.8 mn) to market the new product and establish a demonstration laboratory in the new Skejby Science Park in Århus, where Vivox will move to at the beginning of 2005.


MD Jan Villadsen says the aim is to create a large international company known for its method of cultivating stem cells used for the treatment of diseases where conventional treatment is insufficient.


Vivox has recently sold its first mini-laboratory to Ullevål University Hospital in Oslo, Norway, for a reported price of DKK 2-3 mn (USD 360,000 – 540,000). The news is reported by financial newspaper Børsen.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×